Thyroid disorder decisions — 2025

The Board granted service connection for obstructive sleep apnea (OSA) and remanded the claims for a thyroid condition, a prostate/UTI condition, and vision impairment.

The Board remands the claims for service connection for gastroesophageal reflux disease, obstructive sleep apnea, and hypothyroidism to correct an error by the AOJ to satisfy its duty to assist the Veteran under 38 U.S.C. § 5103A.

The Board granted service connection for hypothyroidism and hypertension, but denied it for an optic nerve abnormality.

The Board denied service connection for a thyroid condition, finding that the evidence does not support a link between the Veteran's in-service exposures and her current hypothyroidism.

The veteran withdrew his appeal for service connection for a thyroid disability and bilateral hearing loss.

The Board remands the case for further development and verification of any additional periods of active duty, ACDUTRA, or INACDUTRA.

The Veteran withdrew her appeals for service connection for various conditions, including arrhythmia and migraine headaches.

The Board granted service connection for coronary artery disease, hypertension, and chronic lymphocytic leukemia but denied it for hypothyroidism.

The Board denied service connection for rectum cancer and remanded the claim for entitlement to service connection for hypothyroidism.

The appeal for special monthly pension (SMP) based on the need for regular aid and attendance or housebound status is remanded to ensure that the appellant receives every possible consideration, including a new VA examination.

The Board remands the claim for an increased rating for thyroid disorder to afford the Veteran a new examination due to her missing the prior scheduled examination and the need to determine the current severity of her disability.

The Board remands the issue of entitlement to service connection for hypothyroidism due to a need for a medical opinion in compliance with the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022 (PACT Act).

The Board denied service connection for both gastroesophageal reflux disease and autoimmune hypothyroidism, finding that the evidence did not support a nexus between these conditions and the Veteran's active service.

The Board denied service connection for hypothyroidism as there is no evidence of an in-service disease, injury, or event related to the condition and no nexus between the current disability and service.

The Board granted service connection for a left knee disability, diagnosed as degenerative arthritis of the left knee. The claim for papillary thyroid carcinoma was remanded for further development.

The Board denied service connection for hypertension, hypothyroidism, bladder cancer, and voiding dysfunction with urinary incontinence as the evidence did not support a finding of chronic disease during or shortly after service, nor was there any credible evidence linking these conditions to herbicide exposure or other in-service events.

The Board granted a 60 percent disability rating for chronic coronary artery disease (CAD) but denied a higher rating for chronic kidney disease.

The Board granted an earlier effective date of February 23, 2017 for the grant of service connection for thyroid endocrine dysfunction.

The Board denied a rating in excess of 70 percent for PTSD and a rating in excess of 20 percent for the lumbar spine back disability, as the evidence did not show symptoms productive of total occupational and social impairment or greater severity.

The Board granted service connection for diabetes mellitus type II, hypertension, hypothyroidism, prostate cancer, sleep apnea secondary to service-connected diabetes mellitus, tinea pedis, and lumbar spondylosis.